FSD Pharma Inc.

HUGE · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$19-$27-$34-$28
Dep. & Amort.$3$5$4$4
Deferred Tax-$8$0-$1-$3
Stock-Based Comp.$4$2$7$8
Change in WC$2-$7$3$1
Other Non-Cash-$1-$1$0-$1
Operating Cash Flow-$11-$28-$21-$19
Investing Activities
PP&E Inv.$0-$0-$1$0
Net Acquisitions$0$0$1$0
Inv. Purchases-$1-$0$0$0
Inv. Sales/Matur.$0$0$0$6
Other Inv. Act.$0$13-$0$0
Investing Cash Flow-$0$12$0$7
Financing Activities
Debt Repay.-$0-$0-$0-$1
Stock Issued$0$0$38$25
Stock Repurch.-$3-$2$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$3-$2$38$24
Forex Effect$0$0$0$0
Net Chg. in Cash-$14-$18$18$12
Supplemental Information
Beg. Cash$17$35$18$6
End Cash$3$17$35$18
Free Cash Flow-$11-$29-$21-$19
FSD Pharma Inc. (HUGE) Financial Statements & Key Stats | AlphaPilot